Kai Chu
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Viral Infections and Outbreaks Research
- Health top 2%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 12
- Viral gastroenteritis research and epidemiology 8
- Epidemiology 17
- Influenza Virus Research Studies 7
- Respiratory viral infections research 7
- Cervical Cancer and HPV Research 5
- Co-authors
- Fengcai Zhu (25 shared papers)Jingxin Li (14 shared papers)Hongxing Pan (15 shared papers)Weidong Yin (3 shared papers)Gang Zeng (2 shared papers)Changgui Li (8 shared papers)Rong Tang (4 shared papers)Yuansheng Hu (6 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (14 papers)Vaccine (5 papers)The Journal of Infectious Diseases (3 papers)The Lancet Infectious Diseases (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Kai Chu
47 papers receiving 1.9k citations
Kai Chu's Hit Papers
Peers
Comparison fields: 5 of 94
- Infectious Diseases 1.3k
- Health 292
- Modeling and Simulation 99
- Cardiology and Cardiovascular Medicine 257
- Parasitology 82
Countries citing papers authored by Kai Chu
This map shows the geographic impact of Kai Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Chu more than expected).
Fields of papers citing papers by Kai Chu
This network shows the impact of papers produced by Kai Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Chu. The network helps show where Kai Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Hit paper breakdown → | 2020 | 971 |
| 2 | 2021 | 183 | |
| 3 | 2015 | 127 | |
| 4 | 2016 | 80 | |
| 5 | 2010 | 61 | |
| 6 | 2012 | 57 | |
| 7 | 2016 | 54 | |
| 8 | 2021 | 38 | |
| 9 | 2012 | 34 | |
| 10 | 2013 | 30 | |
| 11 | 2018 | 29 | |
| 12 | 2019 | 24 | |
| 13 | 2018 | 24 | |
| 14 | 2015 | 23 | |
| 15 | 2022 | 18 | |
| 16 | 2013 | 15 | |
| 17 | 2016 | 15 | |
| 18 | 2017 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2019 | 13 |
About Kai Chu
Kai Chu is a scholar working on Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine, Genetics and Health, having authored 51 papers that have together received 1.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), Viral Infections and Immunology Research (12 papers), Viral gastroenteritis research and epidemiology (8 papers), Influenza Virus Research Studies (7 papers), Respiratory viral infections research (7 papers), Cervical Cancer and HPV Research (5 papers), Vaccine Coverage and Hesitancy (4 papers) and Bacterial Infections and Vaccines (3 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Health (292 citations), Modeling and Simulation (99 citations), Cardiology and Cardiovascular Medicine (257 citations) and Parasitology (82 citations). Kai Chu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Fengcai Zhu, Jingxin Li, Hongxing Pan, Weidong Yin, Gang Zeng, Changgui Li, Rong Tang, Yuansheng Hu, Weixiao Han and Yan Song. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Vaccine, The Journal of Infectious Diseases, The Lancet Infectious Diseases and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.